Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Thrombosis Research|February 5, 2003
Epitope specificity of anti-FVIII antibodies during immune tolerance therapy with factor VIII preparation containing von Willebrand factorAde Kallas, Margus Pooga, Abdellah Benhida, et al.Blood|March 31, 2010
Activation of human endothelial cells from specific vascular beds induces the release of a FVIII storage poolTina Shahani, Renaud Lavend'homme, Aernout Luttun, et al.The Journal of Allergy and Clinical Immunology|March 9, 2006
Three-dimensional structure and IgE-binding properties of mature fully active Der p 1, a clinically relevant major allergenSonia de Halleux, Enrico Stura, Luc VanderElst, et al.Blood|April 20, 2002
Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis modelInderjit Singh, Alberto Smith, Beatrijs Vanzieleghem, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2010
Retroviral vectors induce epigenetic chromatin modifications and IL-10 production in transduced B cells via activation of toll-like receptor 2Roxana R Ahangarani, Wim Janssens, Vincent Carlier, et al.Blood|March 30, 2006
FVIII production by human lung microvascular endothelial cellsMarc Jacquemin, Arne Neyrinck, Maria Iris Hermanns, et al.Blood|September 13, 2003
Deletion of alanine 2201 in the FVIII C2 domain results in mild hemophilia A by impairing FVIII binding to VWF and phospholipids and destroys a major FVIII antigenic determinant involved in inhibitor developmentRoseline d'Oiron, Jean-Maurice Lavergne, Renaud Lavend'homme, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2009
In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-term IL-10-dependent antigen-specific unresponsivenessRoxana Roohi Ahangarani, Wim Janssens, Luc VanderElst, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
Models for assessing immunogenicity and efficacy of new therapeutics for the treatment of haemophiliaJean-Marie Saint-Remy, Birgit M Reipert, Dougald M MonroePageof 7